Medication Reconcilitation Upon Hospital AdmissionNCT04395443
The Impact Of Clinical Pharmacists Medication Reconciliation Upon Patients Admission To Reduce Medication Discrepancies.
A study testing medication reconciliation in people with Medication Reconcilitation Upon Hospital Admission, run by Alexandria University at 1 site in Egypt.
Trial summary
It is a quazai one arm study shows the impact of the role of the clinical pharmacists through medication reconciliation to patients admitted to the emergency department .The main aim is to show if the pharmacists intervention is associated with establishing a complete drug history list than the list already presented… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Medication Reconcilitation Upon Hospital Admission
- What is being tested?
- medication reconciliation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 161 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Sep 2020to 30 Nov 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patients with one or more chronic disease / drug.
Who cannot join
- Patients who cannot communicate or have no family members.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Comparative Prospective Interventional Study Shows The Impact Of The Clinical Pharmacists' Role In The Emergency Department In Medication Reconciliation Upon Patients' Admission To Reduce The Medication Discrepancies.
It is a quazai one arm study shows the impact of the role of the clinical pharmacists through medication reconciliation to patients admitted to the emergency department .The main aim is to show if the pharmacists intervention is associated with establishing a complete drug history list than the list already presented in the patient file and taken by the physician .Then a description of the medication errors detected will be done .
Read the detailed description
It is a quazai one arm study in which the pre phase is the detection of the complete and accurate drug history list already presented in the patient file and taken by the physician and the post phase is the detection of the complete and accurate drug history list taken by the clinical pharmacists after medication reconciliation for the same patients.
medication reconciliation will be done as a full diseases and preadmission medications history will be taken from the patients or the family through interviews, revising previous prescriptions and hospital records.
- Preadmission medication history will include medications trade names, doses, frequency and route of administration and treatment duration and also will include the consumption of vitamins or herbs.
- The medication errors will be detected ,calculated and classified according to medication at transitions and clinical handoffs (MATCH) toolkit for medication reconciliation and NCC MERP index.
- Being tested
- medication reconciliation
- Keywords
- Medication reconcilitation, Medication discrepancies, Admission pharmacist
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
medication reconciliationOther
the emergency clinical pharmacists will start medication reconciliation with the admitted patients and a full diseases and preadmission medications history will be taken.A comparison between the accuracy and completeness of drug history lists already presented in the profile and drug history taken by the clinical pharmacists to detect the medication discrepancies
| Study group | Role | What they receive |
|---|---|---|
| patients admitted to emergency department | Experimental | the intervention is the medication reconciliation Receives: Other: medication reconciliation |
What is being measured
The primary outcome is the main question the study is designed to answer.
the total number of complete and accurate drug history list detected in each phase.
to calculate the total number of complete and accurate drug history list taken by the physicians and already presented in the profile (pre phase) and the total number of complete and accurate drug history list taken by the clinical pharmacists after medication reconciliation (post phase).
Measured: 2 months
Detect the number of medication discrepancies and the proportion of the prescriptions with one or more medication discrepancies
Calculate the total number of medication discrepancies detected after medication reconciliation and then calculate and the proportion of the prescriptions with one or more medication discrepancies from the total number of prescriptions.
2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation.
2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation.
2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation.
to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation and NCC MERP index
Measured: 2 months
classification of medication discrepancies
to classify the medication discrepancies according to MATCH toolkit for medication reconciliation and NCC MERP index.
3- to calculate the proportion of the patients detected with one or more medication discrepancies
3- to calculate the proportion of the patients detected with one or more medication discrepancies
3- to calculate the proportion of the patients detected with one or more medication discrepancies to calculate the proportion of the patients detected with one or more medication discrepancies
Measured: 2 months
the total number of complete medication history lists will be written in the patients profiles
to calculate the total number of complete medication history lists will be written in the patients profiles by the clinical pharmacists after their interventions..
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2020
- Study start25 Sep 2020
- Primary completion30 Nov 2020
- Study completion30 Nov 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Medication Reconcilitation Upon Hospital AdmissionStudies of the same condition, open and under way.
- More trials run by Alexandria UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 161 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Heba Shaker, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04395443
- Sponsor's protocol ID
- 0304494
- Status last verified
- Dec 2020
- First submitted
- 16 May 2020
- Last updated
- 13 Oct 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Shaker HO, Sabry AAF, Salah A, Ragab GM, Sedik NA, Ali Z, Magdy D, Alkafafy AM. The impact of clinical pharmacists' medication reconciliation upon patients' admission to reduce medication discrepancies in the emergency department: a prospective quasi-interventional study. Int J Emerg Med. 2023 Dec 15;16(1):89. doi: 10.1186/s12245-023-00568-z.
PubMed 38102544
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparative Prospective Interventional Study Shows The Impact Of The Clinical Pharmacists' Role In The Emergency Department In Medication Reconciliation Upon Patients' Admission To Reduce The Medication Discrepancies.
- ClinicalTrials.gov ID
- NCT04395443
- Acronym / sponsor ID
- 0304494
- Keywords
- Medication reconcilitation, Medication discrepancies, Admission pharmacist
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 161 participants (actual)
- Lead sponsor
- Alexandria UniversityUniversity, hospital or other
- Study start
- 25 Sep 2020 (actual)
- Primary completion
- 30 Nov 2020 (actual)
- Study completion
- 30 Nov 2020 (actual)
- First posted
- 20 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
It is a quazai one arm study shows the impact of the role of the clinical pharmacists through medication reconciliation to patients admitted to the emergency department .The main aim is to show if the pharmacists intervention is associated with establishing a complete drug history list than the list already presented in the patient file and taken by the physician .Then a description of the medication errors detected will be done .
Detailed description
It is a quazai one arm study in which the pre phase is the detection of the complete and accurate drug history list already presented in the patient file and taken by the physician and the post phase is the detection of the complete and accurate drug history list taken by the clinical pharmacists after medication reconciliation for the same patients.
medication reconciliation will be done as a full diseases and preadmission medications history will be taken from the patients or the family through interviews, revising previous prescriptions and hospital records.
- Preadmission medication history will include medications trade names, doses, frequency and route of administration and treatment duration and also will include the consumption of vitamins or herbs.
- The medication errors will be detected ,calculated and classified according to medication at transitions and clinical handoffs (MATCH) toolkit for medication reconciliation and NCC MERP index.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patients admitted to emergency department | Experimental | Other: medication reconciliationthe intervention is the medication reconciliation |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Patients with one or more chronic disease / drug.
Key exclusion criteria (1 listed)
- Patients who cannot communicate or have no family members.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| medication reconciliationthe emergency clinical pharmacists will start medication reconciliation with the admitted patients and a full diseases and preadmission medications history will be taken.A comparison between the accuracy and completeness of drug history lists already presented in the profile and drug history taken by the clinical pharmacists to detect the medication discrepancies | Other | patients admitted to emergency department |
Primary outcome
the total number of complete and accurate drug history list detected in each phase.
Time frame: 2 months
to calculate the total number of complete and accurate drug history list taken by the physicians and already presented in the profile (pre phase) and the total number of complete and accurate drug history list taken by the clinical pharmacists after medication reconciliation (post phase).
Detect the number of medication discrepancies and the proportion of the prescriptions with one or more medication discrepancies
Time frame: 2 months
Calculate the total number of medication discrepancies detected after medication reconciliation and then calculate and the proportion of the prescriptions with one or more medication discrepancies from the total number of prescriptions. 2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. 2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. 2- to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation. to classify the medication discrepancies using Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation and NCC MERP index
classification of medication discrepancies
Time frame: 2 months
to classify the medication discrepancies according to MATCH toolkit for medication reconciliation and NCC MERP index. 3- to calculate the proportion of the patients detected with one or more medication discrepancies 3- to calculate the proportion of the patients detected with one or more medication discrepancies 3- to calculate the proportion of the patients detected with one or more medication discrepancies to calculate the proportion of the patients detected with one or more medication discrepancies
the total number of complete medication history lists will be written in the patients profiles
Time frame: 2 months
to calculate the total number of complete medication history lists will be written in the patients profiles by the clinical pharmacists after their interventions..
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2022.
- Derived from this study: PubMed 38102544Shaker HO, Sabry AAF, Salah A, Ragab GM, Sedik NA, Ali Z, Magdy D, Alkafafy AM. The impact of clinical pharmacists' medication reconciliation upon patients' admission to reduce medication discrepancies in the emergency department: a prospective quasi-interventional study. Int J Emerg Med. 2023 Dec 15;16(1):89. doi: 10.1186/s12245-023-00568-z.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing medication reconciliation in people with Medication Reconcilitation Upon Hospital Admission, run by Alexandria University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the total number of complete and accurate drug history list detected in each phase. (time frame: 2 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04395443, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2022.